Image: Jessica Kourkounis / Stringer via Getty Images
2 min. read
As artificial intelligence systems spread through hospitals and clinics, a growing debate is emerging over whether the technology will ultimately strengthen nursing care—or gradually replace parts of it.
That tension is at the center of a new University of Pennsylvania School of Nursing report, “Artificial Intelligence and Nursing Science: Opportunities, Challenges, Implications, and Guidelines,” published in Nursing Outlook. The paper warns that while AI could reduce paperwork and improve patient monitoring, it also raises concerns about bias, accountability, patient privacy, and whether hospitals may view some nursing functions as replaceable.
“One of the biggest barriers hospitals face in safely adopting AI tools in nursing care is the lack of robust governance and evaluation frameworks,” says Penn Nursing Dean Antonia Villarruel, a co-author of the paper. “Many organizations are eager to adopt AI quickly, but they may not yet have clear standards for validation, fairness assessment, implementation monitoring, or accountability. Another major challenge is integrating AI into real-world clinical workflows. A technically impressive system can still fail if it does not fit how nurses actually deliver care or if it increases burden instead of reducing it.”
The paper examines how artificial intelligence is reshaping nursing science, outlining both its transformative potential and the risks it poses to clinical practice, ethics, and research.
Drawing on a two-day interdisciplinary workshop at Penn, the authors argue that nursing science is uniquely positioned to guide AI integration because of its focus on patient-centered care, clinical workflow, and advocacy. AI can enhance nursing by automating administrative tasks, accelerating research, improving clinical decision-making, and enabling more personalized patient education and care. It also offers new ways to analyze large datasets that help with identifying patient needs and population health risks.
Additionally, Villarruel and the paper’s other authors, LDI Fellows George Demiris, professor of biobehavioral health sciences at Penn Nursing and informatics at the Perelman School of Medicine, and Connie Ulrich, professor of biobehavioral health sciences at Penn Nursing and medical ethics and health policy at the Perelman School of Medicine, address the mounting discussions and tensions surrounding the issue in a Q&A.
Read more at Penn LDI.
Hoag Levins
Image: Jessica Kourkounis / Stringer via Getty Images
(Image: Lance Nelson)
Image: shih-wei via Getty Images
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
(Image: Kevin Monko/Penn Dental Medicine)